Brazil Fines Eli Lilly $11.8M For Sham Patent Litigation
By Matthew Bultman ( June 25, 2015, 7:44 PM EDT) -- Brazil's antitrust regulator said Thursday it had fined pharmaceutical firm Eli Lilly & Co. and a local affiliate 36.6 million Brazilian reals ($11.8 million) for filing sham patent litigation in order to maintain exclusivity of the cancer treatment drug Gemzar....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.